Treatment of gastrointestinal stromal tumors with imatinib and midostaurin

Details for Australian Patent Application No. 2004273605 (hide)

Owner Novartis AG

Inventors Dimitrijevic, Sasa; Fletcher, Jonathan A.; Silberman, Sandra Leta

Agent Davies Collison Cave

Pub. Number AU-B-2004273605

PCT Pub. Number WO2005/027971

Priority 60/504,245 19.09.03 US

Filing date 17 September 2004

Wipo publication date 31 March 2005

Acceptance publication date 31 July 2008

International Classifications

A61K 31/497 (2006.01)

A61K 31/553 (2006.01) - having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

23 March 2006 PCT application entered the National Phase

  PCT publication WO2005/027971 Priority application(s): WO2005/027971

31 July 2008 Application Accepted

  Published as AU-B-2004273605

27 November 2008 Standard Patent Sealed

12 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004273610-Prevention and treatment of inflammation-induced and/or immune-mediated bone loss

2004273598-Oral compositions for the treatment of cellulite